CACI Awarded Prime Position on Multiple-Award Contract to Provide Engineering and Logistics Support to the Joint Program

  CACI Awarded Prime Position on Multiple-Award Contract to Provide
  Engineering and Logistics Support to the Joint Program Executive Office for
  Chemical and Biological Defense

  New Work Will Support Development and Fielding of Chemical and Biological
                Defense Equipment to Protect U.S. Armed Forces

Business Wire

ARLINGTON, Va. -- January 22, 2013

CACI International Inc (NYSE:CACI) announced today that it has been awarded a
prime position on the Engineering-Technical and Logistics Domains of the
Omnibus Program Engineering and Technical Support (OPETS) contract. CACI will
support development and fielding of chemical and biological defense materiel
for the Department of Defense (DoD) Joint Program Executive Office for
Chemical and Biological Defense (JPEO-CBD). With a ceiling value of
approximately $40 million for each of the two domains, the five-year
(three-year base period plus a two-year option period) indefinite
delivery/indefinite quantity contract expands CACI’s presence in its C4ISR
(command, control, communications, computers, intelligence, surveillance, and
reconnaissance) and logistics and material readiness markets.

The JPEO-CBD is responsible for advanced research, development, acquisition,
fielding, and lifecycle support of chemical and biological detection and
reconnaissance systems, protection and decontamination systems, information
management systems, medical technology, and installation and force protection
systems for DoD missions overseas and in the U.S. To help keep Armed Forces
personnel safe from chemical and biological threats, CACI will compete for
task orders to provide JPEO-CBD with subject matter experts on chemical and
biological defense, the development of technical drawings, configuration
management, and logistics analysis and risk management.

CACI has extensive C4ISR experience that includes a long history of support on
programs such as the U.S. Army’s Strategic Services Sourcing (S3) and
Technical Engineering Support Services contracts as well as ongoing support of
development work for the Army’s Stryker Nuclear Biological Chemical
Reconnaissance Vehicle.

John Mengucci, CACI Chief Operating Officer and President of U.S. Operations,
said, “Our extensive involvement in wide-ranging projects in the C4ISR and
logistics arenas will be directly relevant in ensuring the success of the
Joint Program Executive Office for Chemical and Biological Defense’s mission.
We look forward to providing the critical expertise required to help keep our
Armed Forces out of harm’s way.”

According to CACI President and Chief Executive Officer Dan Allen, “We are
excited for this new contract award with the Joint Program Executive Office
and their confidence in CACI to support their critical mission developing
chemical and biological defense solutions for our military. Our global
presence and proven ability to rapidly deploy the technology and solutions
required to support the DoD’s high priority missions are enabling CACI to
partner effectively with agencies throughout the defense community and are key
elements of our strategy to grow our business.”

CACI provides information solutions and services in support of national
security missions and government transformation for Intelligence, Defense, and
Federal Civilian clients. A member of the Fortune 1000 Largest Companies and
the Russell 2000 Index, CACI provides dynamic careers for approximately 14,900
employees working in over 120 offices worldwide.

There are statements made herein which do not address historical facts, and
therefore could be interpreted to be forward-looking statements as that term
is defined in the Private Securities Litigation Reform Act of 1995. Such
statements are subject to factors that could cause actual results to differ
materially from anticipated results. The factors that could cause actual
results to differ materially from those anticipated include, but are not
limited to, the risk factors set forth in CACI’s Annual Report on Form 10-K
for the fiscal year ended June 30, 2012, and other such filings that CACI
makes with the Securities and Exchange Commission from time to time. Any
forward-looking statements should not be unduly relied upon and only speak as
of the date hereof.

CACI-Contract

Contact:

CACI International Inc
Corporate Communications and Media:
Jody Brown, Executive Vice President, Public Relations
(703) 841-7801
jbrown@caci.com
or
Investor Relations:
David Dragics, Senior Vice President, Investor Relations
(866) 606-3471
ddragics@caci.com
 
Press spacebar to pause and continue. Press esc to stop.